GlassScriptPhysician profile
Elizabeth W Killebrew
NPI 1477565083
$11,643.27
in general payments reported to CMS, 2019-2025
35 companies · $4,625 in 2025
The $4,625 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,310 · 2020: $238 · 2021: $498 · 2022: $1,404 · 2023: $678 · 2024: $890 · 2025: $4,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,179 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,178.90 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,598.23 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $539.90 | 2019-2024 | |
| Astellas Pharma US INC | $449.96 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $250.78 | 2021-2025 | |
| Caldera Medical, INC | $220.07 | 2023-2024 | Desara |
| Mayne Pharma Commercial LLC | $177.29 | 2021-2024 | |
| Abbott Laboratories | $141.36 | 2024-2025 | Mitraclip, Eterna |
| Coopersurgical, INC. | $133.16 | 2019-2021 | |
| Amgen INC. | $115.43 | 2019-2022 | |
| Exeltis, USA INC. | $104.40 | 2021-2025 | Slynd |
| Radius Health, INC. | $95.06 | 2019-2023 | Tymlos |
| Scynexis, INC. | $73.40 | 2021-2022 | |
| Biogen, INC. | $65.60 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $59.35 | 2024-2025 | Myfembree |
| Evofem Biosciences, INC. | $52.12 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $49.15 | 2019-2021 | |
| Organon LLC | $48.85 | 2022-2025 | Nexplanon |
| Millicent US INC | $48.37 | 2019-2020 | |
| Shield Therapeutics INC | $42.52 | 2023-2024 | Accrufer |
| Meditrina | $42.34 | 2022-2025 | |
| Boston Scientific Corporation | $33.69 | 2022 | |
| Becton, Dickinson and Company | $33.40 | 2025 | Arista |
| Hologic Sales and Service, LLC | $32.77 | 2022-2023 | Aptima |
| Daiichi Sankyo INC. | $30.27 | 2019-2021 | |
| Avion Pharmaceuticals | $29.76 | 2021-2023 | Balcoltra |
| Allergan, INC. | $27.36 | 2019 | |
| Optumhealth Care Solutions, LLC | $22.55 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Baxter Healthcare | $18.61 | 2024 | Perclot |
| Pfizer INC. | $17.21 | 2024 | |
| Agile Therapeutics, INC. | $16.49 | 2022 | |
| Duchesnay USA Incorporated | $16.29 | 2019 | |
| Smith+Nephew, INC. | $15.87 | 2025 | Pico 14 |
| Medline Industries LP | $15.00 | 2024 | |
| Mylan Pharmaceuticals INC. | $14.58 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Killebrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.